Advertisement
Singapore markets close in 19 minutes
  • Straits Times Index

    3,319.84
    +11.94 (+0.36%)
     
  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     
  • Hang Seng

    18,868.71
    -326.89 (-1.70%)
     
  • FTSE 100

    8,345.97
    -24.36 (-0.29%)
     
  • Bitcoin USD

    69,609.61
    -475.56 (-0.68%)
     
  • CMC Crypto 200

    1,518.59
    +15.93 (+1.06%)
     
  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     
  • Dow

    39,671.04
    -201.95 (-0.51%)
     
  • Nasdaq

    16,801.54
    -31.08 (-0.18%)
     
  • Gold

    2,360.70
    -32.20 (-1.35%)
     
  • Crude Oil

    77.64
    +0.07 (+0.09%)
     
  • 10-Yr Bond

    4.4340
    +0.0200 (+0.45%)
     
  • FTSE Bursa Malaysia

    1,627.98
    +5.89 (+0.36%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,659.99
    +52.77 (+0.80%)
     

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference

PHILADELPHIA, May 6, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at The Citizens JMP Life Sciences Conference on Monday, May 13th at 12:00 pm ET.

(PRNewsfoto/CARISMA Therapeutics Inc.)
(PRNewsfoto/CARISMA Therapeutics Inc.)

An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

ADVERTISEMENT

Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-citizens-jmp-life-sciences-conference-302135910.html

SOURCE Carisma Therapeutics Inc.